Serco Group plc (LON:SRP)

Verve Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,213	1,532	1,774	1,788	1,610	1,468
Market Cap Growth	7.11%	-13.65%	-0.81%	11.12%	9.63%	-25.71%
Enterprise Value	2,996	2,163	2,429	2,383	2,255	1,975
Last Close Price	2.19	1.49	1.56	1.47	1.25	1.09
PE Ratio	47.08	34.66	8.77	11.51	5.30	10.97
Forward PE	13.74	9.46	10.76	11.90	12.67	14.43
PS Ratio	0.46	0.32	0.36	0.39	0.36	0.38
PB Ratio	2.54	1.82	1.72	1.74	1.60	2.05
P/TBV Ratio	-	-	110.19	-	160.96	-
P/FCF Ratio	5.50	3.89	4.70	5.68	4.94	6.48
P/OCF Ratio	5.21	3.65	4.51	5.47	4.60	5.47
PEG Ratio	4.11	3.67	3.67	3.67	3.67	1.14
EV/Sales Ratio	0.62	0.45	0.50	0.53	0.51	0.51
EV/EBITDA Ratio	6.70	8.14	10.61	9.54	9.23	11.48
EV/EBIT Ratio	12.22	9.75	12.86	11.48	10.81	13.42
EV/FCF Ratio	7.45	5.49	6.44	7.57	6.92	8.71
Debt / Equity Ratio	1.10	0.96	0.64	0.69	0.80	1.11
Debt / EBITDA Ratio	2.26	1.98	1.86	1.92	2.29	2.98
Debt / FCF Ratio	2.38	2.05	1.75	2.25	2.48	3.49
Asset Turnover	1.73	1.82	1.82	1.65	1.72	1.73
Inventory Turnover	184.70	177.12	188.31	192.41	193.01	176.76
Quick Ratio	0.89	0.79	0.77	0.71	0.90	1.04
Current Ratio	0.91	0.87	0.87	0.80	0.97	1.12
Return on Equity (ROE)	5.21%	4.74%	19.62%	15.21%	35.27%	21.30%
Return on Assets (ROA)	4.96%	5.26%	4.40%	4.73%	5.07%	4.10%
Return on Capital (ROIC)	7.71%	8.29%	6.88%	7.30%	7.85%	6.75%
Return on Capital Employed (ROCE)	12.00%	13.30%	11.00%	12.00%	11.20%	9.50%
Earnings Yield	2.20%	2.89%	11.41%	8.69%	18.88%	9.11%
FCF Yield	18.17%	25.73%	21.26%	17.60%	20.25%	15.44%
Dividend Yield	1.90%	2.80%	2.19%	1.95%	1.93%	1.28%
Payout Ratio	87.45%	86.88%	16.65%	19.50%	8.72%	-
Buyback Yield / Dilution	5.60%	4.47%	7.10%	2.35%	0.82%	-4.61%
Total Shareholder Return	7.52%	7.28%	9.28%	4.30%	2.75%	-3.33%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.